CAR T: Impact of Recent Approvals on the Referral Process
The discussion examines whether the CAR T-cell referral process differs for in-state vs out-of-state patients, the role of social factors, and any changes or challenges in the referral process following recent CAR T approvals.
Video Player is loading.
EP: 1.Importance of Collaboration between Academic and Community Centers
EP: 2.Referral Process: Streamlining and Challenges Seen
EP: 3.Referral Process: Bispecifics
EP: 4.Similarities and Differences among Bispecifics: BCMA vs non-BCMA
EP: 5.Types of Referrals and Impact of Social Factors on the Referral Process
EP: 6.Managing AEs Seen with Bispecifics
EP: 7.Referral Process: CAR T-Cell Therapy
Now Viewing
EP: 8.CAR T: Impact of Recent Approvals on the Referral Process
EP: 9.Long-Term Monitoring of AEs and Reintegrating Patients back into Community Care
EP: 10.Clinical Pearls about the Referral Process of Bispecifics and CAR-T in RRMM
Video content above is prompted by the following:
- Is the referral process similar/different for in-state vs out-of-state?
- How do social factors play into the referral process?
- With the recent CAR T approval, has the referral process changed or become more challenging?
Recent Videos
Clinical Pearls about the Referral Process of Bispecifics and CAR-T in RRMM
Long-Term Monitoring of AEs and Reintegrating Patients back into Community Care
Referral Process: CAR T-Cell Therapy
Managing AEs Seen with Bispecifics
Types of Referrals and Impact of Social Factors on the Referral Process
Similarities and Differences among Bispecifics: BCMA vs non-BCMA
Referral Process: Bispecifics
Referral Process: Streamlining and Challenges Seen
Importance of Collaboration between Academic and Community Centers
Related Content
